MuRF-1 and Atrogin-1 Protein Expression and Quadriceps Fiber Size and Muscle Mass in Stable Patients with COPD

References

• Seymour JM, Spruit MA, Hopkinson NS, Sathyapala SA, Man WD, Jackson A, Gosker HR, Schols AM, Moxham J, Polkey MI, The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010; 36:81–88.
   PubMed Web of Science ®Google Scholar
• Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier G, Maltais F. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 166:809–813.
   PubMed Web of Science ®Google Scholar
• Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ, Moore AJ, Moxham J, Polkey MI. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62:115–120.
   PubMed Web of Science ®Google Scholar
• Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294:1704–1708.
   PubMed Web of Science ®Google Scholar
• Cai D, Frantz JD, Tawa NE, Jr., Melendez PA, Oh BC, Lidov HG, Hasselgren PO, Frontera WR, Lee J, Glass DJ, Ikkbeta/nf-kappab activation causes severe muscle wasting in mice. Cell 2004; 119:285–298.
   Google Scholar
• Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL, Reid MB. Tnf-alpha acts via p38 mapk to stimulate expression of the ubiquitin ligase atrogin1/mafbx in skeletal muscle. FASEB J 2005; 19:362–370.
   PubMed Web of Science ®Google Scholar
• Agusti A, Morla M, Sauleda J, Saus C, Busquets X. Nf-kappab activation and inos upregulation in skeletal muscle of patients with copd and low body weight. Thorax 2004; 59:483–487.
   PubMed Web of Science ®Google Scholar
• Mercken EM, Hageman GJ, Langen RC, Wouters EF, Schols AM. Decreased exercise-induced expression of nuclear factor-kappab-regulated genes in muscle of patients with copd. Chest 2011; 139:337–346.
   PubMed Web of Science ®Google Scholar
• Natanek SA LR, Gosker H R, Marsh GS, Slot IGMS, Hopkinson NS, Man WD-C, Moxham J, Kemp PR, Schols AMWJ, Polkey MI. Nf-kappa b (nf-κb) and activator protein-1 (ap-1) DNA binding in the quadriceps of copd patients. Thorax 2010; 65:A138–A139.
   Web of Science ®Google Scholar
• Riddoch-Contreras J, George T, Natanek SA, Marsh GS, Hopkinson NS, Tal-Singer R, Kemp P, Polkey MI. P38 mitogen-activated protein kinase is not activated in the quadriceps of patients with stable chronic obstructive pulmonary disease. COPD 2012:142–150.
   PubMedGoogle Scholar
• Lemire BB, Debigare R, Dube A, Theriault ME, Cote CH, Maltais F. Mapk signalling in the quadriceps of patients with chronic obstructive pulmonary disease. J Appl Physiol 2012; 113(1):159–166.
   PubMed Web of Science ®Google Scholar
• Doucet M, Russell AP, Leger B, Debigare R, Joanisse DR, Caron MA, LeBlanc P, Maltais F. Muscle atrophy and hypertrophy signaling in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176:261–269.
   PubMed Web of Science ®Google Scholar
• Plant PJ, Brooks D, Faughnan M, Bayley T, Bain J, Singer L, Correa J, Pearce D, Binnie M, Batt J. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease (COPD). Am J Respir Cell Mol Biol 2010; 424:461–471.
   Google Scholar
• Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF. Prevalence and characteristics of nutritional depletion in patients with stable copd eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993; 147:1151–1156.
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Nhlbi/who global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med 2001; 163:1256–1276.
   PubMedGoogle Scholar
• Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
   PubMed Web of Science ®Google Scholar
• Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26:511–522.
   PubMed Web of Science ®Google Scholar
• Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26:720–735.
   PubMed Web of Science ®Google Scholar
• Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2005; 86:1979–1985.
   PubMed Web of Science ®Google Scholar
• Steiner MC, Barton RL, Singh SJ, Morgan MD. Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002; 19:626–631.
   PubMed Web of Science ®Google Scholar
• Edwards RH, Young A, Hosking GP, Jones DA. Human skeletal muscle function: Description of tests and normal values. Clin Sci Mol Med 1977; 52:283–290.
   PubMedGoogle Scholar
• Polkey MI, Kyroussis D, Hamnegard CH, Mills GH, Green M, Moxham J. Quadriceps strength and fatigue assessed by magnetic stimulation of the femoral nerve in man. Muscle Nerve 1996; 19:549–555.
   PubMed Web of Science ®Google Scholar
• Ats statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166:111–117.
   PubMed Web of Science ®Google Scholar
• Hopkinson NS, Man WD, Dayer MJ, Ross ET, Nickol AH, Hart N, Moxham J, Polkey MI. Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease. Eur Respir J 2004; 24:137–142.
   PubMed Web of Science ®Google Scholar
• J B. Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 1975; 35:609–616.
   PubMed Web of Science ®Google Scholar
• Russell AP, Wadley G, Hesselink MK, Schaart G, Lo S, Leger B, Garnham A, Kornips E, Cameron-Smith D, Giacobino JP, Ucp3 protein expression is lower in type i, iia and iix muscle fiber types of endurance-trained compared to untrained subjects. Pflugers Arch 2003; 445:563–569.
   PubMed Web of Science ®Google Scholar
• Verdijk LB, Koopman R, Schaart G, Meijer K, Savelberg HH, van Loon LJ. Satellite cell content is specifically reduced in type ii skeletal muscle fibers in the elderly. Am J Physiol Endocrinol Metab 2007; 292:E151–157.
   PubMed Web of Science ®Google Scholar
• Natanek S.A, Gosker HR, Slot IGM, Marsh GS, Hopkinson NS, Man WD-C, Tal-Singer RM, Moxham J, Kemp PR, Schols AMWJ, Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (copd); implications for stratified medicine? Muscle Nerve 2012; in press still PMID 23553751.
   Google Scholar
• Rennie MJ. Muscle protein turnover and the wasting due to injury and disease. Br Med Bull 1985; 41:257–264.
   PubMed Web of Science ®Google Scholar
• Rennie MJ, Edwards RH, Emery PW, Halliday D, Lundholm K, Millward DJ. Depressed protein synthesis is the dominant characteristic of muscle wasting and cachexia. Clin Physiol 1983; 3:387–398.
   PubMedGoogle Scholar
• Rennie MJ, Harrison R. Effects of injury, disease, and malnutrition on protein metabolism in man. Unanswered questions. Lancet 1984; 1:323–325.
   PubMed Web of Science ®Google Scholar
• Petersen AM, Magkos F, Atherton P, Selby A, Smith K, Rennie MJ, Pedersen BK, Mittendorfer B. Smoking impairs muscle protein synthesis and increases the expression of myostatin and mafbx in muscle. Am J Physiol Endocrinol Metab 2007; 293:E843–848.
   PubMed Web of Science ®Google Scholar
• Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2008; 3:637–658.
   PubMedGoogle Scholar
• Rabinovich RA, Vilaro J. Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med 2010; 16:123–133.
   PubMed Web of Science ®Google Scholar
• de Boer MD, Selby A, Atherton P, Smith K, Seynnes OR, Maganaris CN, Maffulli N, Movin T, Narici MV, Rennie MJ. The temporal responses of protein synthesis, gene expression and cell signalling in human quadriceps muscle and patellar tendon to disuse. J Physiol 2007; 585:241–251.
   PubMed Web of Science ®Google Scholar
• Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA, Walsh SL, Bloch SA, Sidhu PS, Hart N, Quadriceps wasting and physical inactivity in patients with copd. Eur Respir J 40(5):1115–1122.
   PubMed Web of Science ®Google Scholar
• Rennie MJ, Smith K, Watt PW. Measurement of human tissue protein synthesis: An optimal approach. Am J Physiol 1994; 266:E298–307.
   PubMed Web of Science ®Google Scholar
• Hopkinson NS, Tennant RC, Dayer MJ, Swallow EB, Hansel TT, Moxham J, Polkey MI. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res 2007; 8:25.
   PubMed Web of Science ®Google Scholar
• Lewis A, Riddoch-Contreras J, Natanek SA, Donaldson A, Man WD, Moxham J, Hopkinson NS, Polkey MI, Kemp PR. Downregulation of the serum response factor/mir-1 axis in the quadriceps of patients with COPD. Thorax 2012; 67:26-34.
   PubMed Web of Science ®Google Scholar
• Donaldson AV, Natanek SA, Man WD-C, Kemp PR and Polkey MI. Increased skeletal muscle-specific microrna-1 in the blood of COPD patients. Thorax 2012; 65:A25.
   Google Scholar
• Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P, Bouillon R, Decramer M. Muscle force during an acute exacerbation in hospitalised patients with copd and its relationship with cxcl8 and igf-i. Thorax 2003; 58:752–756.
   PubMed Web of Science ®Google Scholar